Data / Form D filings / Myris Therapeutics, Inc.
Myris Therapeutics, Inc.: Form D filing
Myris Therapeutics, Inc., a biotechnology company in Sharpsburg, PA, filed a Form D with the SEC in 2026. The latest, on October 14, 2026, reports $500,000 sold of a $4.5 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 307 23RD ST. EXT SUITE 150, Sharpsburg, PA, 15215
- Phone
- (412) 816-5315
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1924725
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 14 | New notice | $4,500,000 | $500,000 | $4,000,000 | 4 | Sep 1 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Laura E. Benjamin | Executive Officer, Director | |
| Rebecca Wolfe | Executive Officer | |
| Antonina Simakova | Executive Officer | |
| Alan Russell | Promoter | |
| David N. Colaizzi | Director | |
| Barbara S. Fox | Director | |
| Krzysztof Matyjaszewski | Director | |
| Mark A. Murcko | Director |
Every Form D from the week of Oct 12 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Myris Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.